AI-Powered Treatment Outcome Prediction for Lymphoma Therapy
Our partner, a healthcare technology provider, sought to improve treatment planning for lymphoma patients.
The goal was to build an AI solution that could predict treatment outcomes early, enabling doctors to choose optimal strategies before beginning therapy.
Solution
Unidatalab developed an AI-powered outcome prediction model trained on real-world clinical datasets and electronic medical records. By analyzing patient histories, drug responses, comorbidities, and outcomes, the model helps doctors determine the most effective course of treatment from the very beginning.
How it works
The system processes thousands of anonymized patient records, learning patterns from historical treatment decisions and outcomes.
Using neural networks and ensemble machine learning, the model evaluates a range of factors: disease stage, prior medications, comorbidities (e.g., renal or bronchiolar disease), and exposure to specific drugs.
The AI predicts the likelihood of response to various treatment options and highlights key influencing factors to support clinical interpretation.
The output is delivered as a decision-support tool that offers explainable predictions, reducing uncertainty and improving early treatment alignment.
Our challenges:
Delayed response to ineffective treatments
Many lymphoma patients spend months on standard therapies that ultimately fail, wasting valuable time and worsening prognosis.
Choosing between aggressive vs. gentle therapies
Doctors often face a difficult decision: use aggressive treatment with serious side effects, or risk under-treatment with gentler options.
Too much data, too few actionable insights
Electronic medical records and clinical histories contain valuable information, but analyzing them manually is time-consuming and inconsistent.
Project stages
Collected structured and unstructured clinical data from anonymized EMRs and clinical trial records. Standardized inputs and engineered features around diagnosis, history, treatment regimen, and observed outcomes.
Trained a deep learning model combining neural networks with interpretable feature scoring to evaluate outcome likelihood. Integrated confidence scores and risk factors for physician review.
Benchmarked model performance against retrospective patient data. Clinical partners reviewed prediction accuracy and interpretability to validate use in real-world decision-making.
Delivered a secure, API-accessible tool that integrates into clinical workflows. The system offers real-time predictions for new patients while maintaining data privacy standards.
Summary
